Biovac signs tech transfer agreement for Cholera vaccine production

Biovac, a South African based Bio-pharmaceutical company has concluded a ground-breaking licensing and technology transfer agreement with the South Korean International Vaccine Institute (IVI) for the manufacture of an oral cholera vaccine (OCV). This is one of the remaining steps in the vaccine manufacturing value chain that is currently missing across the African vaccine manufacturing…